The Journal of arthroplasty
The Journal of arthroplasty
Audio Summaries
Every issue of The Journal of arthroplasty moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from The Journal of arthroplasty.
Stratified Diagnostic Thresholds by Infection Chronicity Resolve the Controversy in Unicompartmental Knee Arthroplasty Periprosthetic Joint Infection: A Prospective Study.
Nov 20, 2026
This prospective single-center study of 77 revision unicompartmental knee arthroplasty patients asked whether synovial fluid markers (white blood cell count, polymorphonuclear percentage, and neutrophil gelatinase-associated lipocalin, NGAL) should use different diagnostic cutoffs for acute versus chronic periprosthetic joint infection. ROC analysis showed that acute infection required higher cutoffs (SF-WBC >10,020/μL, PMN% >81%) than chronic infection (SF-WBC <2,770/μL, PMN% >62%), and synovial NGAL performed strongly in both groups. Because the study is small, exploratory, and lacks external validation, the authors conclude that these chronicity-specific thresholds need confirmation in larger multicenter cohorts before routine clinical use.
There is a Marked Temporal Variation in the Level of Serological Markers Used for Diagnosis of Periprosthetic Joint Infection.
Nov 20, 2026
This study examined whether ESR and CRP levels change over time enough in patients awaiting revision arthroplasty to alter periprosthetic joint infection (PJI) diagnoses. In a cohort of 218 patients with repeated pre-revision measurements, ESR rose about 5.9% per day when initially low, and CRP fell about 4.9% per day when initially high, with the greatest variability seen when initial ESR was low. The authors conclude that these temporal fluctuations can move results above or below MSIS diagnostic thresholds, potentially compromising the accuracy of serological testing for PJI.
Complications and Failures following Extensor Mechanism Reconstruction in Revision Total Knee Arthroplasty.
Nov 20, 2026
This study used a national claims database to compare complications and treatment failures (including fusion or amputation) in revision total knee arthroplasty with versus without extensor mechanism reconstruction (EMR), in both septic and aseptic cases. The authors asked whether adding EMR increases the risk of wound problems, reoperations, and ultimately arthrodesis or amputation. They found that EMR was linked to higher rates of wound dehiscence in both groups and, in aseptic revisions specifically, to greater odds of subsequent debridement, grafting, flap procedures, and amputation, suggesting the added soft-tissue burden drives amputation risk.
Outcomes in Men versus Women After Primary Total Knee Arthroplasty: A Systematic Review.
Nov 19, 2026
This systematic review asked whether outcomes after primary total knee arthroplasty differ between men and women, synthesizing 24 studies covering about 2.6 million patients. The authors found that men generally reported slightly higher PROM scores, but these differences were usually below the minimal clinically important difference and often disappeared after adjusting for preoperative status, while men showed higher rates of infection, reoperation, and revision. They conclude that sex-based differences are small and may reflect worse preoperative health in women rather than an independent effect of sex, though the evidence is not entirely consistent.
Intra-Articular Injection Into a Nonoperative Joint Within 90 Days Before Total Knee Arthroplasty is Associated With Increased Revision.
Nov 19, 2026
This retrospective cohort study of over 1 million patients undergoing primary total knee arthroplasty asked whether an intra-articular injection into a nonoperative joint within 90 days before surgery increases the risk of revision. Injection was associated with higher revision hazard at one year (HR 1.43) and six months (HR 1.52), but not at 90 days, and this association was driven mainly by periprosthetic joint infection. The authors suggest recent injection into a non-knee joint may matter for perioperative risk assessment, though the mechanism remains unclear.
Association Between Quantitatively Assessed Lateral Trochlear Osteophyte Severity and Three-Year Outcomes After Medial Unicompartmental Knee Arthroplasty.
Nov 19, 2026
This retrospective cohort study of 221 knees undergoing medial unicompartmental knee arthroplasty asked whether the severity of lateral trochlear osteophytes (LTO), quantified on Merchant-view radiographs using a novel joint space occupancy ratio (JSOR), affects patient-reported outcomes. At three years, patients with an LTO had slightly higher pain scores (VAS 2.0 vs 1.7) and lower Kujala scores (87.5 vs 89.2) than those without, with more severe osteophytes (JSOR ≥50%) associated with somewhat worse results. However, these differences fell below minimal clinically important difference thresholds, and over 95% of patients in all groups achieved meaningful improvement, so the authors suggest JSOR may aid counseling but should not guide decisions alone.
Xa Inhibitors Are Associated with an Increased Risk of Manipulation after Primary Total Knee Arthroplasty Compared to Aspirin in a Contemporary Cohort.
Nov 18, 2026
This study asked whether factor Xa inhibitors (rivaroxaban, apixaban) used for VTE prophylaxis after primary total knee arthroplasty increase the risk of manipulation under anesthesia (MUA) compared with aspirin, and how the two Xa inhibitors compare. Using a database of 435,789 unilateral primary TKAs from 2021 to 2023, the authors found MUA within 90 days occurred more often with Xa inhibitors than aspirin (3.9% vs 2.8%), with an adjusted odds ratio of 1.60 for Xa inhibitors. Rivaroxaban had similar unadjusted MUA rates to apixaban but lower adjusted odds (OR 0.89), suggesting Xa inhibitors are associated with higher MUA risk, though this is an observational association.
Defining the Patient Acceptable Symptom State for the 12-Item Knee Injury and Osteoarthritis Outcome Score at One Year After Total Knee Arthroplasty.
Nov 18, 2026
This study aimed to establish patient acceptable symptom state (PASS) thresholds for the KOOS-12 at one year after primary total knee arthroplasty, defining the score above which patients consider their outcome acceptable. Using 1,370 patients from a prospective registry, the authors anchored PASS values to a five-item satisfaction scale (AUC >0.8 for all domains) and derived thresholds via the Youden Index, yielding cutoffs of 75 (pain), 88 (function), 67 (quality of life), and 76 (summary). These benchmarks can help clinicians and researchers determine which patients have achieved a successful outcome after knee arthroplasty.
Certain Second-Generation Antipsychotics Increase Risk of Complications Following Total Hip Arthroplasty.
Nov 18, 2026
Using a large national database, this study asked whether preoperative second-generation antipsychotic (SGA) use affects outcomes after total hip arthroplasty. After propensity-score matching 10,818 patients (5,409 SGA-exposed and matched non-users), SGA exposure within one year before surgery was associated with higher two-year risks of revision THA (RR 1.6), periprosthetic fracture (RR 2.0), surgical site infection (RR 1.4), and all-cause mortality (RR 2.0). The authors conclude that these findings support closer perioperative optimization, medication review, and postoperative surveillance for patients taking SGAs.
The 10- Year Clinical and Radiographic Outcomes of a Vitamin E-Infused Highly Cross-Linked Polyethylene Cup in Total Hip Arthroplasty: A Multicenter Cohort Study.
Nov 18, 2026
This multicenter prospective study asks whether an uncemented monoblock acetabular cup made of vitamin E-stabilized highly cross-linked polyethylene (VEPE) maintains durable outcomes beyond five years, a period where long-term evidence is limited. Among 675 hips followed for a mean of about 10.6 years, the authors found a 10-year Kaplan-Meier survivorship of 98.7%, with only three cup revisions, substantial Harris Hip Score improvement, and low rates of radiographic lucent lines (12.8%) and osteolysis (3.2%) without clinical consequences. However, complete clinical and radiographic data were available for only 40.4% of hips at final follow-up, which should be considered when interpreting these results.
